These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17118778)

  • 1. Is there any association between nek3 and cancers with frequent 13q14 deletion?
    Hernández M; Almeida TA
    Cancer Invest; 2006 Nov; 24(7):682-8. PubMed ID: 17118778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer.
    Latil A; Morant P; Fournier G; Mangin P; Berthon P; Cussenot O
    Int J Cancer; 2002 Jun; 99(5):689-96. PubMed ID: 12115502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning and characterization of the human NIMA-related protein kinase 3 gene (NEK3).
    Kimura M; Okano Y
    Cytogenet Cell Genet; 2001; 95(3-4):177-82. PubMed ID: 12063396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma.
    Riou P; Saffroy R; Comoy J; Gross-Goupil M; Thiéry JP; Emile JF; Azoulay D; Piatier-Tonneau D; Lemoine A; Debuire B
    Clin Cancer Res; 2002 Oct; 8(10):3178-86. PubMed ID: 12374686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.
    Emi M; Fujiwara Y; Nakajima T; Tsuchiya E; Tsuda H; Hirohashi S; Maeda Y; Tsuruta K; Miyaki M; Nakamura Y
    Cancer Res; 1992 Oct; 52(19):5368-72. PubMed ID: 1356616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
    Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
    Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer.
    Ueda T; Emi M; Suzuki H; Komiya A; Akakura K; Ichikawa T; Watanabe M; Shiraishi T; Masai M; Igarashi T; Ito H
    Genes Chromosomes Cancer; 1999 Mar; 24(3):183-90. PubMed ID: 10451697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome bands 3p14.2, 9p21, and 13q14 are frequently deleted in roentgenographically occult bronchogenic squamous cell carcinoma of the lung.
    Sato M; Sakurada A; Sagawa M; Endo C; Tanita T; Kondo T; Tsuchiya E; Fujimura S; Horii A
    Genes Chromosomes Cancer; 1998 Dec; 23(4):367-70. PubMed ID: 9824211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon.
    Zinda MJ; Johnson MA; Paul JD; Horn C; Konicek BW; Lu ZH; Sandusky G; Thomas JE; Neubauer BL; Lai MT; Graff JR
    Clin Cancer Res; 2001 Aug; 7(8):2475-9. PubMed ID: 11489829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia.
    Herholz H; Kern W; Schnittger S; Haferlach T; Dicker F; Haferlach C
    Cancer Genet Cytogenet; 2007 Apr; 174(1):57-60. PubMed ID: 17350468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [13q14 aberration is related to the metastatic potential of human NSCLC].
    Huang Y; Yang HJ; Jin Y; Li HM; Fu SB
    Yi Chuan; 2005 Jul; 27(4):531-4. PubMed ID: 16120571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
    Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
    Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.
    Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT
    Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin gene alterations in hepatocellular carcinoma.
    Wang F; Denison S; Lai JP; Philips LA; Montoya D; Kock N; Schüle B; Klein C; Shridhar V; Roberts LR; Smith DI
    Genes Chromosomes Cancer; 2004 Jun; 40(2):85-96. PubMed ID: 15101042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
    Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
    Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel human tissue factor splice variant that is upregulated in tumor cells.
    Chand HS; Ness SA; Kisiel W
    Int J Cancer; 2006 Apr; 118(7):1713-20. PubMed ID: 16217771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer.
    Jarrard DF; Bova GS; Ewing CM; Pin SS; Nguyen SH; Baylin SB; Cairns P; Sidransky D; Herman JG; Isaacs WB
    Genes Chromosomes Cancer; 1997 Jun; 19(2):90-6. PubMed ID: 9171999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells.
    Miller SL; Antico G; Raghunath PN; Tomaszewski JE; Clevenger CV
    Oncogene; 2007 Jul; 26(32):4668-78. PubMed ID: 17297458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.